EUVIMEDOntdek EUVIMED
CrossrefInfokaart

Anastomotic leakage increases the risk of major low anterior resection syndrome 3 years after rectal cancer surgery

Anders Gerdin, Jenny Häggström, Jennifer Park, Marie‐Louise Lydrup, Peter Matthiessen, Henrik Jutesten, Sofia Sandberg, Eva Angenete, Martin Rutegård

Colorectal Disease · 2026-03 · 28 (3)

DOI: 10.1111/codi.70423 ↗
SamenvattingBibliografische gegevens

Samenvatting

Abstract Background Anastomotic leakage is a serious complication following anterior resection for rectal cancer and may increase the risk of long‐term bowel dysfunction. This study aimed to assess the long‐term impact of anastomotic leakage on major low anterior resection syndrome (major LARS) at a uniform follow‐up time. Methods We conducted a nationwide cohort study using the Swedish Colorectal Cancer Registry. Patients who underwent anterior resection for rectal cancer between 2015 and 2017 received the validated LARS questionnaire by mail 3 years after surgery. The primary outcome was major LARS among patients without a permanent stoma. Propensity score weighting was used to adjust for confounding, with covariates chosen using a directed acyclic graph. Sensitivity analyses included a dose–response analysis based on reoperation and an evaluation of a composite outcome of major LARS or permanent stoma. Results Of 1778 patients contacted, 1178 responded (66.2%). Among 1033 stoma‐free patients, 52 (5.0%) had experienced a symptomatic anastomotic leak. Major LARS was reported in 69.2% and 52.9% of patients with and without leakage, respectively. Symptomatic anastomotic leakage increased the risk of major LARS (OR 2.09; 95% CI: 1.13–3.87) and this risk was higher in patients requiring reintervention (OR 2.78; 95% CI: 0.87–8.91) and when including permanent stoma in the outcome (OR 3.90; 95% CI: 2.20–6.91). Conclusion Anastomotic leakage significantly increased the risk of major LARS 3 years after anterior resection for rectal cancer. These findings underscore the importance of preventing anastomotic leakage to reduce long‐term functional morbidity in patients who survive rectal cancer.

Kennis die bij uw werk past.

Van een gratis start via persoonlijk literatuuronderzoek tot de volledige Research Suite.

Tarieven bekijken →

Zijn alle volledige uitgeversteksten inbegrepen?

Nee. Bibliografische records, abstracts en volledige teksten zijn verschillende inhoudstypen. Beschikbaarheid hangt af van bron, open access en bestaande licenties. Een EUVIMED-abonnement vervangt geen aanvullende uitgeversrechten.

Tarieven bekijken →